🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Showing page 29 of 857 · Phase 3 first, then by program name

  1. Barley beta-glucan(3.0g)

    Hospital Authority, Hong Kong

    Overweight; Hyperlipidemia

    phase 3 other completed

    1 trial

  2. Bavencio 20 mg/mL concentrate for solution for infusion

    Merck Sharp and Dohme

    Solid Tumors

    phase 3 small molecule active

    1 trial

  3. Baxdrostat

    AstraZeneca

    Uncontrolled Hypertension

    phase 3 small molecule completed

    2 trials

  4. Baxdrostat

    AstraZeneca

    Primary Hyperaldosteronism

    phase 3 small molecule active

    1 trial

  5. Baxdrostat, Baxdrostat Placebo

    AstraZeneca AB

    Resistant hypertension (rHTN) defined as blood pressure that remains higher than goal levels despite the use of at least 3 anti hypertensive drugs of different classes at maximum tolerated dose, including a diuretic.

    phase 3 small molecule active

    1 trial

  6. Baxdrostat, Baxdrostat Placebo, Baxdrostat

    AstraZeneca AB

    Uncontrolled hypertension (uTHN) defined as blood pressure that remains higher than goal levels despite patients being treated with 2 anti-hypertensive agents, including a diuretic. Resistant hypertension (rHTN) defined as blood pressure that remains higher than goal levels despite the use of at least 3 anti hypertensive drugs of different classes at maximum tolerated dose, including a diuretic.

    phase 3 small molecule active

    1 trial

  7. Baxdrostat, Baxdrostat, Baxdrostat Placebo

    AstraZeneca AB

    Primary Aldosteronism defined by excess aldosterone secretion

    phase 3 small molecule active

    1 trial

  8. Baxdrostat, Baxdrostat, Baxdrostat, Forxiga 10 mg film-coated tablets, Baxdrostat placebo

    AstraZeneca AB

    Chronic kidney disease (CKD) and hypertension.

    phase 3 small molecule active

    1 trial

  9. Baxdrostat, Forxiga 10 mg film-coated tablets, Baxdrostat, Baxdrostat placebo

    AstraZeneca AB

    Chronic kidney disease (CKD) and hypertension.

    phase 3 small molecule active

    1 trial

  10. Beclomethasone Dipropionate 640

    Teva Pharma GmbH

    Persistent Asthma

    phase 3 small molecule completed

    1 trial

  11. Beclomethasone dipropionate

    Teva Pharma GmbH

    Seasonal Allergic Rhinitis

    phase 3 small molecule completed

    1 trial

  12. Beclomethasone dipropionate

    Teva Pharma GmbH

    Rhinitis, Allergic, Perennial

    phase 3 small molecule completed

    1 trial

  13. Beclomethasone dipropionate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    2 trials

  14. Beclomethasone dipropionate BAI

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  15. Beclomethasone dipropionate breath-actuated inhaler

    Teva Pharma GmbH

    Persistent Asthma

    phase 3 small molecule completed

    1 trial

  16. Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol

    Teva Pharma GmbH

    Rhinitis, Allergic, Perennial

    phase 3 small molecule completed

    1 trial

  17. Bedaquiline

    BRIGHT MINDS BIOSCIENCES INC.

    Multi-drug Resistant Tuberculosis

    phase 3 small molecule active

    1 trial

  18. Bedaquiline (B)

    The First People's Hospital of Lianyungang

    Pulmonary Tuberculosis

    phase 3 small molecule active

    1 trial

  19. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Behavior Therapy

    phase 3 other completed

    1 trial

  20. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    HCV Negative Status

    phase 3 other completed

    1 trial

  21. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 3 other completed

    3 trials

  22. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Abuse

    phase 3 other completed

    1 trial

  23. Behavior therapy

    United Therapeutics Europe Ltd

    Autism Spectrum Disorder

    phase 3 other active

    1 trial

  24. Behavioral Drug and HIV Risk Reduction Counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    phase 3 other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources